The global disease control and prevention vaccine market is anticipated to grow at a considerable CAGR of 12.1% during the forecast period (2022-2028). All the major players in the global disease control and prevention vaccine market are involved in strategic alliances such as acquisitions, partnerships, and collaborations to launch new vaccines to stay competitive in the market. For instance, in February 2021, US FDA approved the COVID-19 vaccine of Johnson and Johnson Services Inc., as emergency use authorization for its single dose vaccine to prevent COVID-19 in individuals above 18 years.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/disease-control-and-prevention-vaccine-market
Further, several vaccine manufacturers are working in partnership with WHO, UNICEF, and Global Alliance for Vaccine and Immunization (GAVI) to improve the vaccination program globally for reducing the number of patients suffering from diseases. Additionally, the Global Vaccine Action Plan was also endorsed by the 194 members of WHO in May 2012 with the main motive to prevent millions of deaths by 2020 through more equitable access to existing vaccines for the people in all communities. A part from this, in February 2022, WHO announced the first technology recipients for the mRNA vaccine that includes Egypt, Kenya, Nigeria, Senegal, South Africa, and Tunisia.
Market Coverage
- The market number available for – 2022-2028
- Base year- 2022
- Forecast period- 2022-2028
- Segment Covered-
o By Type
o By Indication
- Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
- Competitive Landscape – AstraZeneca, Astellas Pharma Inc., Blistex Inc., Church & Dwight Co., Inc., Serum Institute of India Pvt. Ltd., and many more
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
- Who is the leader in the market?
- How are players addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Disease Control and Prevention Vaccine Market Report Segment
By Type
- Live-Attenuated Vaccine
- Inactivated Vaccine
- Subunit Vaccine
- Toxoid Vaccine
- Others
By Indication
- infectious Disease
- Cancer
- Other Indication
A full report of Disease Control and Prevention Vaccine Market is available at: https://www.omrglobal.com/industry-reports/disease-control-and-prevention-vaccine-market
Disease Control and Prevention Vaccine Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- 3M
- Bristol-Myers Squibb Co.
- Colgate-Palmolive Co.
- Daiichi Sankyo Co. Ltd.
- Emergent BioSolutions Inc.EMERGENT
- GlaxoSmithKline Plc.
- Johnson & Johnson Services Inc.
- Merck & Co., Inc.
- Pfizer Inc.
- Sanofi
- Sinovac Biotech Ltd.SIVONAC
- VBI Vaccines Inc.
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
